July 8, 2015
BioBridge Global CEO Linda Myers has a mission: She believes San Antonio has proven that it is an ideal host site for the World Stem Cell Summit and plans to call on organizers to consider bringing the international conference back to the Alamo City. BioBridge Global has a subsidiary, QualTex Laboratories, which has a presence […]
Read more
February 4, 2015
New Organ, a collective initiative for biomedical engineering and regenerative medicine, announced today that two new teams have joined the field competing for the New Organ Liver Prize, a global competition sponsored by the Methuselah Foundation, a biomedical charity. The prize challenge will award $1,000,000 to the first team that creates a regenerative or bioengineered […]
Read more
December 11, 2014
The three-day World Stem Cell Summit may have concluded on Friday, Dec. 5, but its impact on San Antonio could be felt for decades, said StemBioSys co-founder Steven Davis, who was also one of the bioscience industry leaders responsible for bringing the global conference to the city. What did San Antonio gain from hosting the […]
Read more
December 5, 2014
Nearly $20 million in grants and awards available including $10 million grand prize SAN ANTONIO (DEC. 4, 2014) – Conquer Paralysis Now (CPN) has launched a groundbreaking competition to cure paralysis in the next 10 years. The announcement was made by Ida Cahill, president and CEO of CPN, at the World Stem Cell Summit in […]
Read more
December 3, 2014
https://www.youtube.org/watch?v=BVRV5EL0ehM SAN ANTONIO, December 3, 2014 — The Genetics Policy Institute (GPI), producer of the annual World Stem Cell Summit, and the Regenerative Medicine Foundation (RMF) have agreed to merge in order to leverage their resources in the advancement of stem cell research, regenerative medicine and other advanced technologies targeting cures. They made a joint […]
Read more
November 26, 2014
PALO ALTO, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) — Cellular Biomedicine Group Inc. (Nasdaq:CBMG) (the “Company”), a biomedicine firm engaged in the development of effective treatments for degenerative and cancerous diseases, today announced that Dr. William (Wei) Cao, Chief Executive Officer of the Company, will present “48-week Clinical Results from Phase IIa Trial of Human […]
Read more
November 26, 2014
Texans for Stem Cell Research (TSCR), proudly announces its participation in the World Stem Cell Summit, 2014 in San Antonio November 25th, 2014 | Texans for Stem Cell Research (TSCR), proudly announces its participation in the World Stem Cell Summit, 2014 in San Antonio, Texas, December 2-5th, 2014. TSCR will co- host a Welcoming Party […]
Read more